We are a vibrant young company committed to science first. Our mission is to develop and deliver the unprecedented accuracy of TwinStrand Duplex Sequencing™ technology for applications in clinical medicine and life sciences where it can do the greatest good for the greatest number of people. Our approach is multifaceted and encompasses internal development projects, external collaborations and empowering of partner organizations.
TwinStrand Duplex Sequencing™ technology is an ultra-high accuracy, error-corrected sequencing method that overcomes the limitations of NGS by independently tracking both strands of individual DNA molecules. Utilizing our multi-patented novel chemistry and cloud-based bioinformatics, the paired sequences are compared to eliminate errors, reducing error rates from 1-in-100 to 1-in-10 million, revealing ultra-low frequency variants.
Employees: 51-200
Total raised: $66M
Founded date: 2015
Investors 3
| Date | Name | Website |
| - | S32 | s32.com |
| - | Madrona Ve... | madrona.co... |
| - | Sahsen Ven... | sahsen.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 06.05.2021 | Series B | $50M | - |
| 07.01.2020 | Series A | $16M | - |
Mentions in press and media 10
| Date | Title | Description | Source |
| 07.10.2022 | TwinStrand CEO and co-founder steps down from Seattle biotec... | Jesse Salk, co-founder of TwinStrand. (TwinStrand Photo) TwinStrand Biosciences’ co-founder Jesse Sa... | geekwire.c... |
| 10.05.2021 | TwinStrand Biosciences lands $50M | TwinStrand Biosciences, a genomics startup developing technology to identify ultra-low frequency DNA... | pitchbook.... |
| 07.05.2021 | TwinStrand Biosciences Inks $50M Series B | SEATTLE, WA, TwinStrand Biosciences has closed a $50 million Series B financing led by Section 32.... | vcnewsdail... |
| 06.05.2021 | TwinStrand Biosciences raises $50M to increase adoption of D... | While much of the world is still getting on board with next-generation sequencing technology, many b... | fiercebiot... |
| 06.05.2021 | Grandson of Jonas Salk raises cash to find ‘genetic needles ... | Jesse Salk, CEO and co-founder of TwinStrand Biosciences. (TwinStrand Photo) New funding: Gene-seque... | geekwire.c... |
| 06.05.2021 | TwinStrand Biosciences : Announces $50 Million Series B to E... | TwinStrand Biosciences, the pioneer and developer of Duplex Sequencing, an ultra-high accuracy techn... | marketscre... |
| 16.01.2020 | Seattle-Based TwinStrand Biosciences Raises $16 Million | Novel genetic sequencing technology company TwinStrand Biosciences announced it has raised $16 milli... | pulse2.com... |
| 07.01.2020 | TwinStrand Biosciences Raises $16M in Series A Funding | TwinStrand Biosciences, a Seattle, WA-based novel genetic sequencing technology company, closed a $1... | finsmes.co... |
| 30.08.2018 | University of Washington spin-out raising cash for more accu... | BigStock Photo TwinStrand Biosciences, a spin-out of the University of Washington, is raising cash t... | geekwire.c... |
| - | TwinStrand Biosciences | “TwinStrand Biosciences - An end-to-end solution, from pre-sequencing biochemistry to post-sequencin... | fastfounde... |